Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patients ; volume:23 ; number:1 ; day:4 ; month:6 ; year:2024 ; pages:1-16 ; date:12.2024
Molecular cancer ; 23, Heft 1 (4.6.2024), 1-16, 12.2024
- Creator
-
Qiao, Xiaohang
Zanden, Sabina Y. van der
Li, Xiaoyang
Tan, Minkang
Zhang, Yunxiang
Song, Ji-Ying
Gelder, Merle A. van
Hamoen, Feija L.
Janssen, Lennert
Zuur, Charlotte L.
Pang, Baoxu
Tellingen, Olaf van
Li, Junmin
Neefjes, Jacques
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12943-024-02034-7
- URN
-
urn:nbn:de:101:1-2408112103121.141765660299
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Qiao, Xiaohang
- Zanden, Sabina Y. van der
- Li, Xiaoyang
- Tan, Minkang
- Zhang, Yunxiang
- Song, Ji-Ying
- Gelder, Merle A. van
- Hamoen, Feija L.
- Janssen, Lennert
- Zuur, Charlotte L.
- Pang, Baoxu
- Tellingen, Olaf van
- Li, Junmin
- Neefjes, Jacques
- SpringerLink (Online service)
Other Objects (12)
Juvenile competitive triathlete after cardiotoxic anthracycline therapy for Acute Myeloid Leukemia
Anthracycline Chemotherapy and Cardiotoxicity
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
Metabolic Aspects of Anthracycline Cardiotoxicity
Cardioprotection strategies for anthracycline cardiotoxicity
CMR assessment of myocardial mechanics and tissue characterization in patients treated with Anthracycline chemotherapy for acute myeloid leukaemia
Novel Anthracycline Utorubicin for Cancer Therapy
Novel Anthracycline Utorubicin for Cancer Therapy
Beiträge zum Prodrug-Konzept : Synthese bifunktioneller Anthracycline und asymmetrische Diels-Alder-Reaktionen zum Aufbau enantiomerenreiner Anthracycline
Comparison of anthracycline-containing and anthracycline-free regimens in neoadjuvant HER-2 positive breast cancer treatment
Anti-cancer effects of ginsenoside compound k on pediatric acute myeloid leukemia cells
Anthracycline‑Induced Cardiac Toxicity: A Clinical Review
Juvenile competitive triathlete after cardiotoxic anthracycline therapy for Acute Myeloid Leukemia
Anthracycline Chemotherapy and Cardiotoxicity
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
Metabolic Aspects of Anthracycline Cardiotoxicity
Cardioprotection strategies for anthracycline cardiotoxicity
CMR assessment of myocardial mechanics and tissue characterization in patients treated with Anthracycline chemotherapy for acute myeloid leukaemia
Novel Anthracycline Utorubicin for Cancer Therapy
Novel Anthracycline Utorubicin for Cancer Therapy
Beiträge zum Prodrug-Konzept : Synthese bifunktioneller Anthracycline und asymmetrische Diels-Alder-Reaktionen zum Aufbau enantiomerenreiner Anthracycline
Comparison of anthracycline-containing and anthracycline-free regimens in neoadjuvant HER-2 positive breast cancer treatment
Anti-cancer effects of ginsenoside compound k on pediatric acute myeloid leukemia cells
Anthracycline‑Induced Cardiac Toxicity: A Clinical Review
Juvenile competitive triathlete after cardiotoxic anthracycline therapy for Acute Myeloid Leukemia
Anthracycline Chemotherapy and Cardiotoxicity
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
Metabolic Aspects of Anthracycline Cardiotoxicity
Cardioprotection strategies for anthracycline cardiotoxicity
CMR assessment of myocardial mechanics and tissue characterization in patients treated with Anthracycline chemotherapy for acute myeloid leukaemia
Novel Anthracycline Utorubicin for Cancer Therapy
Novel Anthracycline Utorubicin for Cancer Therapy
Beiträge zum Prodrug-Konzept : Synthese bifunktioneller Anthracycline und asymmetrische Diels-Alder-Reaktionen zum Aufbau enantiomerenreiner Anthracycline
Comparison of anthracycline-containing and anthracycline-free regimens in neoadjuvant HER-2 positive breast cancer treatment
Anti-cancer effects of ginsenoside compound k on pediatric acute myeloid leukemia cells